ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 047,60
-0,90%
Dow Jones
41 911,71
-2,08%
DAX
22 620,95
-1,65%
Brent Oil
69,035
-0,01%
Bitcoin
79 837,10
1,75%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. CASI Pharmaceuticals Inc (CASI) Cours

CASI Pharmaceuticals Inc

CASI Pharmaceuticals Inc (CASI)

NASDAQ
2,24
0,04
(1,82%)
Fermé 11 Mars 9:00PM
Retardé de 15 minutes
2,24
0,00
(0,00%)
Après les heures de négociation: 12:56AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
2,24
Prix Achat
2,01
Prix Vente
2,34
Volume échangé
4 626
2,20 Fourchette du Jour 2,33
2,05 Plage de 52 semaines 7,67
Cap du marché
34,631M
Clôture Veille
2,20
Ouverture
2,20
Dernière Transaction
50
@
2.24
Dernière heure de transaction
Volume financier
US$ 10 342
VWAP
2,2355
Volume moyen (3 m)
25 101
Actions en circulation
15 460 457
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,28
Bénéfice par action (BPA)
-1,74
Chiffre d'affairess
40,25M
Bénéfice net
-26,96M

À propos de CASI Pharmaceuticals Inc

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before a... CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.casipharmaceuticals.com
Siège social
Grand Cayman, Cym
Fondé
-
CASI Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker CASI. Le dernier cours de clôture d'CASI Pharmaceuticals était de US$2,20. Au cours de la dernière année, les actions de CASI Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 2,05 à US$ 7,67.

CASI Pharmaceuticals compte actuellement 15 460 457 actions en circulation. La capitalisation boursière d'CASI Pharmaceuticals est de US$34,01 million. CASI Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -1.28.

CASI Dernières nouvelles

Plus de nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
10 Février 2025
CASI (1,82%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
21 Janvier 2025
CASI (1,82%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
02 Janvier 2025
CASI (1,82%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
26 Décembre 2024
CASI (1,82%)

Form F-3/A - Registration statement by foreign private issuers: [Amend]
Edgar (US Regulatory)
23 Décembre 2024
CASI (1,82%)

Form F-3 - Registration statement by foreign private issuers
Edgar (US Regulatory)
20 Décembre 2024
CASI (1,82%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
16 Décembre 2024
CASI (1,82%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
15 Novembre 2024
CASI (1,82%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
12 Septembre 2024
CASI (1,82%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.08-3.448275862072.322.492.1550892.26014416CS
4-0.24-9.677419354842.482.652.1582422.41794553CS
12-0.89-28.43450479233.133.472.15251012.74230907CS
26-4.09-64.61295418646.337.672.15313964.28337915CS
52-2.5-52.74261603384.747.672.05881894.49444349CS
156-6.76-75.1111111111910.31.451171214.73124291CS
260-16.36-87.956989247318.6391.4546435814.37002889CS

CASI - Frequently Asked Questions (FAQ)

What is the current CASI Pharmaceuticals share price?
The current share price of CASI Pharmaceuticals is US$ 2,24
How many CASI Pharmaceuticals shares are in issue?
CASI Pharmaceuticals has 15 460 457 shares in issue
What is the market cap of CASI Pharmaceuticals?
The market capitalisation of CASI Pharmaceuticals is USD 34,01M
What is the 1 year trading range for CASI Pharmaceuticals share price?
CASI Pharmaceuticals has traded in the range of US$ 2,05 to US$ 7,67 during the past year
What is the PE ratio of CASI Pharmaceuticals?
The price to earnings ratio of CASI Pharmaceuticals is -1,28
What is the cash to sales ratio of CASI Pharmaceuticals?
The cash to sales ratio of CASI Pharmaceuticals is 0,86
What is the reporting currency for CASI Pharmaceuticals?
CASI Pharmaceuticals reports financial results in USD
What is the latest annual turnover for CASI Pharmaceuticals?
The latest annual turnover of CASI Pharmaceuticals is USD 40,25M
What is the latest annual profit for CASI Pharmaceuticals?
The latest annual profit of CASI Pharmaceuticals is USD -26,96M
What is the registered address of CASI Pharmaceuticals?
The registered address for CASI Pharmaceuticals is PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1-1104
What is the CASI Pharmaceuticals website address?
The website address for CASI Pharmaceuticals is www.casipharmaceuticals.com
Which industry sector does CASI Pharmaceuticals operate in?
CASI Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CAPSCapstone Holding Corp
US$ 3,11
(1 144,00%)
74,5k
HMRHeidmar Maritime Holdings Corporation
US$ 2,5599
(69,53%)
37,58M
RDFNRedfin Corporation
US$ 9,76
(67,70%)
92,54M
CKPTCheckpoint Therapeutics Inc
US$ 3,9895
(61,52%)
60,92M
STSSSharps Technology Inc
US$ 0,4399
(48,26%)
591,61M
SXTCChina SXT Pharmaceuticals Inc
US$ 2,78
(-35,54%)
162,75k
PCLAPicoCELA Inc
US$ 0,8499
(-35,12%)
866,61k
CONLGraniteShares ETF Trust GraniteShares
US$ 15,685
(-34,86%)
8,71M
MSTXTidal Trust II Defiance Daily Target 2x Long MSTR ETF
US$ 19,22
(-32,95%)
24,19M
JVACoffee Holdings Co
US$ 6,53
(-31,77%)
988,94k
STSSSharps Technology Inc
US$ 0,4399
(48,26%)
591,61M
NVDANVIDIA Corporation
US$ 106,98
(-5,07%)
364,12M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7,3701
(-30,86%)
258,67M
TSLATesla Inc
US$ 222,15
(-15,43%)
188,57M
TQQQProShares UltraPro QQQ
US$ 59,81
(-11,27%)
155,18M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CASI
CASI Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces